Hybrid Membrane-Coated Nanoplatform Enables Pyroptosis-Driven Photothermal Immunotherapy via Synergistic STING/TLR4 Activation
ACS Applied Materials & Interfaces · 11.11.2026 · 18 (44) · 60549-60568
DOI: 10.1021/acsami.6c16166 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 29.10.2026. Verfasst von Qian Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Te…. Hauptthemen laut MEDLINE: Pyroptosis, Toll-Like Receptor 4, Photothermal Therapy, Immunotherapy. Die Arbeit nennt 65 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
The immunosuppressive tumor microenvironment (TME) remains a major barrier to effective cancer immunotherapy, largely due to deficient activation of innate immune pathways and insufficient immune cell infiltration. To address this issue, we developed a hybrid biomimetic nanoplatform (CL8-BO NPs + CLPS) that encapsulates a near-infrared photothermal agent (L8-BO) and the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide, respectively, and is surface-functionalized with a mixed macrophage–red blood cell membrane, with the two components used in synergy. Upon 808 nm laser irradiation, L8-BO generated localized hyperthermia, inducing gasdermin D-dependent pyroptosis, which released cytosolic DNA and damage-associated molecular patterns to activate the stimulator of interferon genes (STING) pathway. Concurrently, released lipopolysaccharide engaged TLR4 signaling, potentiating innate immune activation. In a subcutaneous 4T1 breast carcinoma model, intratumoral administration of CL8-BO NPs followed by laser irradiation remodeled the immunosuppressive TME by promoting dendritic cell maturation, enhancing intratumoral CD8+ cytotoxic T lymphocyte infiltration by 5-fold, and suppressing regulatory T cells and myeloid-derived suppressor cells. The combination therapy inhibits tumor growth by over 90%. This nanoplatform provides a promising strategy for converting “cold” tumors into “hot” tumors through photothermal–triggered pyroptosis and synergistic STING/TLR4 activation in a localized delivery model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Materials, Chemistry and Chemical Engineering, Ha…
- State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai201620, P.R. China.
- Laboratory Animal Center, Hangzhou Normal University, Hangzhou311121, P.R. China.
ORCID-Profile: Shouchun Yin
Förderung
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Niu, Q., Chen, Y., Fang, L., Ma, X., Cheng, M., Chen, X., Gu, M., Li, Y., & Yin, S. (2026). Hybrid Membrane-Coated Nanoplatform Enables Pyroptosis-Driven Photothermal Immunotherapy via Synergistic STING/TLR4 Activation. ACS Applied Materials & Interfaces, 18(44), 60549-60568. https://doi.org/10.1021/acsami.6c16166
Vancouver
Niu Q, Chen Y, Fang L, Ma X, Cheng M, Chen X, et al. Hybrid Membrane-Coated Nanoplatform Enables Pyroptosis-Driven Photothermal Immunotherapy via Synergistic STING/TLR4 Activation. ACS Applied Materials & Interfaces. 2026;18(44):60549-60568. doi:10.1021/acsami.6c16166
BibTeX
@article{Niu2026,
author = {Niu, Qian and Chen, Yaofeng and Fang, Lu and Ma, Xiaoying and Cheng, Miaoyan and Chen, Xueying and Gu, Meier and Li, Yang and Yin, Shouchun},
title = {Hybrid Membrane-Coated Nanoplatform Enables Pyroptosis-Driven Photothermal Immunotherapy via Synergistic STING/TLR4 Activation},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {44},
pages = {60549--60568},
doi = {10.1021/acsami.6c16166}
}
EUVIMED